Effect of Intermittent Fasting Among Adult Population (IF)

March 22, 2024 updated by: Zahara Ali Rizvi, University of the Punjab

Effect of Intermittent Fasting on Body Composition, Clinical Health Markers and Memory Status Among Adult Population: A Randomized Control Trial

Our study aims to assess the effects of intermittent fasting among the healthy population.

Study Overview

Detailed Description

Research needs to be conducted to find the effects of intermittent fasting on humans as it might not have the same favorable effects on the memory of a human brain compared to mice. This study will also help to assess the consequences of different intermittent fasting regimens on different individuals (based on age, sex, body mass index , memory status and physical activity etc)

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Lahore, Punjab, Pakistan, 12345
        • University of the Punjab

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • BMI greater or equal to 25kg/m2.

Exclusion Criteria:

not given consent having secondary or syndromic forms of obesity taking medication for weight gain or reduction undergoing bariatric surgery

  • diabetic pregnant women breastfeeding mothers chronic disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intermittent Fasting Group
eight hours eating window and 16 hours for fasting among healthy population
16 hours fasting and 8 hours eating window
Placebo Comparator: Control group
Normal routine diet
normal diet without any customization
Active Comparator: Customized Dietary group
Customized diet plan according to participants' calorie intake and according to their respective Body Mass Index
The customized diet plan will be given to the participants according to their calorie intake requirements

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight(in kg)
Time Frame: three months
For BMI
three months
Height (in cm)
Time Frame: three months
for BMI
three months
Waist (in cm)
Time Frame: three months
for waist hip ratio
three months
Hip measurement(in cm)
Time Frame: three months
for waist hip ratio
three months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Health Markers
Time Frame: three months
Low Density Lipid, Very Low Density Lipid, High Density Lipid, triglycerides
three months
blood sugar
Time Frame: three months
Fasting blood sugar level
three months
blood pressure
Time Frame: three months
Diastolic and systolic blood pressure
three months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Memory Status
Time Frame: three months
scoring system higher the value good will be results
three months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Javeria Saleem, Ph.D, University of the Punjab

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2022

Primary Completion (Actual)

August 11, 2023

Study Completion (Actual)

August 15, 2023

Study Registration Dates

First Submitted

August 10, 2022

First Submitted That Met QC Criteria

August 25, 2022

First Posted (Actual)

August 30, 2022

Study Record Updates

Last Update Posted (Actual)

March 26, 2024

Last Update Submitted That Met QC Criteria

March 22, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

participants assessment report regarding intermittent fasting

IPD Sharing Time Frame

three months

IPD Sharing Access Criteria

access should be given when data entry completed

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Informed Consent Form (ICF)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intermittent Fasting

Clinical Trials on Intermittent Fasting

Subscribe